RIS Notification
ALBA 2006-1 PLC (the "Issuer")
Optional Redemption Notice
£119,100,000 A3a Notes due 2037 (ISIN: XS0254830499)
£80,000,000 A3b Notes due 2037 (ISIN: XS0254831893)
£54,750,000 B Notes due 2037 (ISIN: XS0254833089)
£19,200,000 C Notes due 2037 (ISIN: XS0254833758)
£13,600,000 D Notes due 2037 (ISIN: XS0254834053)
£9,200,000 E Notes due 2037 (ISIN: XS0254834301)
(together, the "Notes")
The Notes are admitted to the official list of the Irish Stock Exchange plc trading as Euronext Dublin and to trading on its regulated market.
This announcement contains inside information and is made by the Issuer pursuant to Regulation (EU) No. 596/2014 (the "Market Abuse Regulation") and Regulation (EU) 2016/1055 (the "Implementing Technical Standards") relating thereto.
Capitalised terms used, but not defined herein, shall have the meaning given thereto in the Prospectus dated 16 June 2006 in relation to the issue and offering of the Notes.
NOTICE IS HEREBY GIVEN that.
1. pursuant to Condition 5(d) of the Notes, on 24 July 2020, the holder of 100 per cent. of the Principal Amount Outstanding of the Subordinated Notes directed the Issuer to redeem all of the Notes pursuant to a written notice of direction;
2. the Issuer intends to redeem all the Notes on 24 August 2020; and
3. in accordance with the conditions to redemption under Condition 5(d), the Issuer has the necessary funds, not subject to any interest of any other person, required to redeem the Notes and to pay or make provision for all amounts ranking in priority thereto.
Noteholders who have queries in relation to the above matters should contact the Issuer via email on corpservices@lawdeb.com.
This notice is given by:
ALBA 2006-1 PLC
Dated 27 July 2020
This announcement has been issued through the Companies Announcement Service of Euronext Dublin.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.